USPTO serial 98043421
LUXRX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PAYABYAB, EDWARD TAN
- Law office
- TMO LAW OFFICE 128
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LUXRX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicated liquid soaps; Medicated balms for treatment of skin care, pain management, discomfort, ache, muscle and joint; Medicated candies; Medicated candy; Medicated chewing gum; Medicated compresses; Medicated cosmetics; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated diaper rash cream; Medicated diaper rash lotions; Medicated diaper rash ointment; Medicated diaper rash ointments and lotions; Medicated facial cleansers; Medicated foot bath preparations; Medicated grooming preparations for hair care, skin care, etc., namely, hair loss and skin complexion; Medicated lotions for sunburn; Medicated lotions for treating dermatological conditions; Medicated lotions for skin care, pain management, discomfort, ache, muscle and joint; Medicated lozenges; Medicated make-up; Medicated massage oils; Medicated moisturizers; Medicated mouthwash; Medicated mouthwash for treating gingivitis; Medicated oils containing cannabis, herbs, hemp, extracts, vitamins; Medicated ointments for treating dermatological conditions; Medicated pre-moistened tissues; Medicated serums for treatment of skin care, pain management, discomfort, ache, muscle and joint; Medicated shampoo; Medicated shampoos; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin preparation for use in treating pain, discomfort, muscle ache; Medicated skin soap; Medicated skin toners; Medicated soap; Medicated soap for foot perspiration; Medicated sun block; Medicated sun screen; Medicated sunburn lotions; Medicated sunburn ointments; Medicated sunscreen; Medicated sweets; Medicated toothpaste; Medicated topical solution that increases the efficacy and percutaneous absorption of benzoyl peroxide; Medicated wart removing preparations; Syrups for pharmaceutical purposes for the treatment of coug, itc.h, cold, pain, discomfort; Acne medications; Allergy medication; Allergy medications; Allergy relief medication; Ampoules sold filled with medicated serums for treatment of dermatological conditions; Burn relief medication; Candy, medicated; Cough syrups; Cough syrups for medical use; Diarrhea medication; Fungal medications; Medicinal syrups containing each or all of the following in various combinations: cannibis and hemp extract, herbs, vitamins, medications for the treatment of any condition including but not limited to cough, cold, ache and pain, skin conditions and etc.; Medicinal syrups for the treatment of skin conditions, aches and pains; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Non-medicated topical gel for the prevention and treatment of allergies; Non-medicated topical gel for the prevention and treatment of cold and flu; Non-medicated, therapeutic skin creams for the treatment of skin care, pain management, discomfort, ache, muscle and joint; Nutritional supplements in the form of syrups, pills, capsules, ointments, creams, etc.; Pain relief medication; Plant and herb extracts sold as components of medicated cosmetics; Stimulatory medications for use in weight reduction programs; Transdermal patches featuring cannabis and hemp extract with or without other ingredients, including medications, herbs and vitamins; Veterinary preparations, namely, pain relief medication | ACTIVE | Jun 14, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 26, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 26, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 27, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 19, 2023 | NWAP | NEW APPLICATION ENTERED | — |